Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    

Global Drug Delivery Formulations Market Research Report

PRODUCT TITLE PUBLISHED
North American Transmucosal Drug Delivery Market North American Transmucosal Drug Delivery Market
The North American Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.26 billion in 2013 and expected to be $1.70 billion by 2018, growing at a CAGR of 6.2%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
European Transmucosal Drug Delivery Market European Transmucosal Drug Delivery Market
The European Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.81 billion in 2013 and expected to be $1.07 billion by 2018, growing at a CAGR of 5.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Asian Transmucosal Drug Delivery Market Asian Transmucosal Drug Delivery Market
The Asian Transmucosal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $0.48 billion in 2013 and expected to be $0.72 billion by 2018, growing at a CAGR of 8.8%. The Transmucosal Drug Delivery Market analyzes the market by segments such as Oral (Buccal and Sublingual), and others (Rectal, Vaginal).The prominent players in the Market BioDelivery Sciences International, Inc., Merck, NovaDel Pharma, Inc., Reckitt Benckiser Group plc., Cephalon and CIMA Labs.
Upcoming
Asian Topical Drug Delivery Market Asian Topical Drug Delivery Market
The Asian Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $1.54 billion in 2013 and expected to be $2.10 billion by 2018, growing at a CAGR of 6.4%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
European Topical Drug Delivery Market European Topical Drug Delivery Market
The European Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $2.64 billion in 2013 and expected to be $2.96 billion by 2018, growing at a CAGR of 2.3%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
North American Topical Drug Delivery Market North American Topical Drug Delivery Market
The North American Topical Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance,huge investment made by big pharmaceutical companies.The Market was Valued at $4.23 billion in 2013 and expected to be $4.90 billion by 2018, growing at a CAGR of 3.0%. The Topical Drug Delivery Market analyzes the market by segments such as Semi-Solid Formulations, Liquid Formulations, and Solid Formulations.The prominent players in the Market are Galderma S.A., Stiefel Laboratories, Inc., Valeant Pharmaceuticals International, Inc.
Upcoming
26 reports | Show
Connect With Us
US/CAN : +1-888-502-0539